Boston-based research center wins $15m to fight hepatitis C

E-mail | Print | Comments () Posted by Elizabeth Cooney July 23, 2009 01:55 PM

Facebook
E-mail

A research collaboration based in Boston has won a five-year, $15 million grant to study how the hepatitis C virus defies immune system efforts to defeat it.

The Cooperative Center for Translational Research in Human Immunology, which will be based at Massachusetts General Hospital, won the grant from the National Institute of Allergy and Infectious Diseases, the hospital said. Dr. Raymond Chung, director of hepatology in the MGH Gastrointestinal Unit, will co-direct the new center with Dr. Paul Klenerman of Oxford University.

The center also includes researchers from MIT, Harvard, the Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and the Wistar Institute, in Philadelphia.

Hepatitis C is a viral, blood-borne disease that can cause a life-threatening liver infection. Some people recover from the infection, but for most people the illness is chronic. The center will explore how the immune system fails to suppress and remove the virus.

Facebook
E-mail

« Back to front page

About white coat notes

White Coat Notes covers the latest from the health care industry, hospitals, doctors offices, labs, insurers, and the corridors of government. Chelsea Conaboy previously covered health care for The Philadelphia Inquirer. Write her at cconaboy@boston.com. Follow her on Twitter: @cconaboy.

Daily Dose | More Health&Wellness

health answers

Long-term health consequences to being born prematurely? It's estimated that each year nearly 500,000 babies in the United States are born prematurely, or before 37 weeks of pregnancy. Submit question | More answers